Submitted on Monday 17th April 2017
Rejected on Tuesday 25th April 2017
Current status: Rejected
Rejection code: no-action (see below for details)
Continue to provide the hormone T3 to certain patients with hypothyroidism.
The government have the T3 hormone (liothyronine) therapy on a list of drugs that will no longer be available, as they believe that the cost out weighs the benefits. Many hypothyroids rely on this hormone to function normally
In a recent study the results showed that a patients genes plays a significant role as to whether the replacement therapy for Hypothyroidism should include the T3 as well as the T4 hormone. T4 and T3 are hormones produced by the thyroid gland and are essential for life. The thyroid produces mainly T4, which is then converted to T3 in tissue and organs. T3 is the active hormone.
I call on the government to continue to allow the T3 therapy as for some hypothyroids the benefits are enormous
You can't sign this petition because it was rejected. But you can still comment on it here at Repetition.me!
The Government e-Petitions Team gave the following reason:
NHS England will be leading a review of low value prescription items from April 2017 and will be introducing new guidance for Clinical Commissioning Groups (CCGs). This review is still going on, and the guidance hasn't been issued yet.
You can find out more about the review here:
www.england.nhs.uk/2017/03/guidance-on-low-value-prescription-items/
This explains that "NHS England will work with clinicians and clinical commissioning groups to develop guidelines initially around a set of 10 medicines which are ineffective, unnecessary, inappropriate for prescription on the NHS, or indeed unsafe, and that together cost the NHS £128m per year. In developing the guidance, the views of patient groups, clinicians, commissioners and providers across the NHS will be sought."
You can also find more information here:
www.nhscc.org/latest-news/400m-high-priority-areas/
3.22.249.158 Fri, 19 Apr 2024 11:11:28 +0100
